Save the Date: 2025 Donald G. Doehring Memorial Lecture
Thursday March 27th 2025 • 4:30pm to 6pm Leacock Building #232, 855 Sherbrooke West
Lori Leibold Ph.D. Senior Director • Center for Hearing Research
Speaker Bio

Fourteen McGillians appointed to the Order of Canada
Governor General recognizes McGill community members for exceptional accomplishments and serviceFourteen members of the McGill University community have been appointed to the Order of Canada, one of the country’s highest civilian honours.
Among the honourees are the University’s Chancellor and three professors:

An open solution to improving research reproducibility
Academic and industry scientists collaborate on a new method to characterize research antibodiesStructural Genomics Consortium researchers at The Neuro (Montreal Neurological Institute-Hospital) of McGill University, in collaboration with scientists from 11 major antibody manufacturers representing approximately 80 per cent of global renewable antibody production, have developed and standardized an Open Science platform to characterize research antibodies.

Quebec government awards $1.6 million to McGill researchers providing innovative solutions for industry
McGill-led projects in genomics, imaging, and manufacturing serve businesses across Quebec

Prix Grands Sages honours McGill professor emeritus Dr. Phil Gold and two PhD candidates
Researchers’ outstanding contributions to science and society celebrated by the Fonds de recherche du Québec

Fifteen new or renewed Canada Research Chairs awarded to McGill
$13.8 million in federal funding for McGill’s cohort of 10 new, five renewed Canada Research Chairs

Open Science project funded for $1.5M
YCharOS antibody characterization platform addresses the “reproducibility crisis” in researchAn innovative research project led by researchers at The Neuro has been awarded $1.5M by the Government of Quebec through CQDM.
YCharOS is an innovative platform led by neuroscientists Peter McPherson and Carl Laflamme that validates antibody reagents for human proteins.

At-home neurological disorder diagnosis project receives major funding
$1M grant from The Weston Family Foundation will pave the way for earlier intervention in REM sleep behaviour disorder and Parkinson’s diseaseREM sleep behaviour disorder (RBD) is an often debilitating condition that causes people to act out in their sleep, sometimes violently. What’s worse, people with the disorder often go on to develop Parkinson’s disease.

FREE Hearing Screening
No apppointment needed.
First come, first serve.
Thank you

Caring Conversations - Home care or care home?
Caring Conversations is an online forum for care partners of people living with dementia to learn from experts, share concerns and ask questions.

McGill researchers’ studies offer promise for lung and brain cancer treatment
Two seminal studies from McGill University, investigating immune landscapes of lung and brain tumours, were published today in Nature. This work was led by Logan Walsh, Daniela Quail and Peter Siegel, researchers at the Rosalind and Morris Goodman Cancer Institute and Philippe Joubert from Université Laval.
Message from VP-Dean Eidelman - The Faculty's Return to Campus
Dear Faculty of Medicine and Health Sciences Colleagues,

Marathon of Hope Cancer Centres Network accelerates precision medicine plan with signing of Contribution Agreement with Health Canada
Vancouver, BC -- The Government of Canada and the Terry Fox Research Institute (TFRI) have jointly signed a Contribution Agreement which opens the door for the Marathon of Hope Cancer Centres Network to begin operating.
McGill researcher-led International Task Force unveils first-of-its kind standards for treatment of obsessive-compulsive disorder
By David McFadden
Listed by the World Health Organization among the ten leading causes of medical disability worldwide, the severity of obsessive-compulsive disorder (OCD) is at a level on par with cancer. This prevalent disorder is characterized by highly distressing intrusive thoughts and repeated compulsive behaviours such as washing or checking.

Two cellular pathways involved in TNBC tumour development and a promising targeted combination therapy
A team of researchers at the RI-MUHC found two cellular pathways involved in TNBC tumour development and a promising targeted combination therapy
Source: RI-MUHC